Lonafarnib is indicated for use to cut back the risk of Demise due to Hutchinson-Gilford progeria syndrome and with the treatment method of specific other processing-deficient progeroid laminopathies in people today just one year of age and more mature.[three][4]Acceptance was according to complete scientific evidence supporting its efficacy and pr